|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:EPHX2-BNIP3L (FusionGDB2 ID:26981) |
Fusion Gene Summary for EPHX2-BNIP3L |
Fusion gene summary |
Fusion gene information | Fusion gene name: EPHX2-BNIP3L | Fusion gene ID: 26981 | Hgene | Tgene | Gene symbol | EPHX2 | BNIP3L | Gene ID | 2053 | 665 |
Gene name | epoxide hydrolase 2 | BCL2 interacting protein 3 like | |
Synonyms | ABHD20|CEH|SEH | BNIP3a|NIX | |
Cytomap | 8p21.2-p21.1 | 8p21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | bifunctional epoxide hydrolase 2epoxide hydrataseepoxide hydrolase 2, cytoplasmicepoxide hydrolase 2, cytosolicepoxide hydrolase, soluble | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-likeBCL2/adenovirus E1B 19 kDa protein-interacting protein 3ABCL2/adenovirus E1B 19-kd protein-interacting protein 3aBCL2/adenovirus E1B 19kDa interacting protein 3 likeNIP-3-like protein XNIP3 | |
Modification date | 20200327 | 20200313 | |
UniProtAcc | . | O60238 | |
Ensembl transtripts involved in fusion gene | ENST00000521400, ENST00000517536, ENST00000521780, ENST00000380476, ENST00000518379, ENST00000520666, | ENST00000380629, ENST00000523515, ENST00000520409, ENST00000518611, ENST00000521254, | |
Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 9 X 8 X 6=432 |
# samples | 4 | 11 | |
** MAII score | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(11/432*10)=-1.97352778863881 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EPHX2 [Title/Abstract] AND BNIP3L [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EPHX2(27401761)-BNIP3L(26265516), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | EPHX2-BNIP3L seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. EPHX2-BNIP3L seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. EPHX2-BNIP3L seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EPHX2 | GO:0010628 | positive regulation of gene expression | 18974052 |
Hgene | EPHX2 | GO:0016311 | dephosphorylation | 12574508 |
Hgene | EPHX2 | GO:0042632 | cholesterol homeostasis | 18974052 |
Hgene | EPHX2 | GO:0046272 | stilbene catabolic process | 8342951 |
Hgene | EPHX2 | GO:0046839 | phospholipid dephosphorylation | 12574510 |
Hgene | EPHX2 | GO:0097176 | epoxide metabolic process | 22798687 |
Tgene | BNIP3L | GO:0043065 | positive regulation of apoptotic process | 9973195 |
Tgene | BNIP3L | GO:0043066 | negative regulation of apoptotic process | 10381623 |
Tgene | BNIP3L | GO:0051607 | defense response to virus | 9973195 |
Fusion gene breakpoints across EPHX2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across BNIP3L (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-E9-A1NA-01A | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
ChimerDB4 | BRCA | TCGA-E9-A1NA-01A | EPHX2 | chr8 | 27401761 | - | BNIP3L | chr8 | 26265516 | + |
Top |
Fusion Gene ORF analysis for EPHX2-BNIP3L |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000521400 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521400 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521400 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521400 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
5CDS-3UTR | ENST00000521400 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000517536 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000517536 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000517536 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000517536 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
5CDS-3UTR | ENST00000517536 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521780 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521780 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521780 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000521780 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
5CDS-3UTR | ENST00000521780 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000380476 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000380476 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000380476 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000380476 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
5CDS-3UTR | ENST00000380476 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000518379 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000518379 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000518379 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
Frame-shift | ENST00000518379 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
5CDS-3UTR | ENST00000518379 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
intron-3CDS | ENST00000520666 | ENST00000380629 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
intron-3CDS | ENST00000520666 | ENST00000523515 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
intron-3CDS | ENST00000520666 | ENST00000520409 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
intron-3CDS | ENST00000520666 | ENST00000518611 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
intron-3UTR | ENST00000520666 | ENST00000521254 | EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265516 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for EPHX2-BNIP3L |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265515 | + | 0.000184355 | 0.99981564 |
EPHX2 | chr8 | 27401761 | + | BNIP3L | chr8 | 26265515 | + | 0.000184355 | 0.99981564 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for EPHX2-BNIP3L |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | BNIP3L |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor. {ECO:0000269|PubMed:10381623, ECO:0000269|PubMed:21264228}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for EPHX2-BNIP3L |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for EPHX2-BNIP3L |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EPHX2-BNIP3L |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EPHX2-BNIP3L |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EPHX2 | C0013221 | Drug toxicity | 1 | CTD_human |
Hgene | EPHX2 | C0018801 | Heart failure | 1 | CTD_human |
Hgene | EPHX2 | C0018802 | Congestive heart failure | 1 | CTD_human |
Hgene | EPHX2 | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
Hgene | EPHX2 | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Hgene | EPHX2 | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Hgene | EPHX2 | C0036341 | Schizophrenia | 1 | CTD_human |
Hgene | EPHX2 | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Hgene | EPHX2 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | EPHX2 | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Hgene | EPHX2 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Hgene | EPHX2 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Hgene | EPHX2 | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
Hgene | EPHX2 | C1959583 | Myocardial Failure | 1 | CTD_human |
Hgene | EPHX2 | C1961112 | Heart Decompensation | 1 | CTD_human |
Hgene | EPHX2 | C2609414 | Acute kidney injury | 1 | CTD_human |